Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 21, 2020; 26(35): 5302-5313
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5302
Table 1 Trends in patient characteristics according to decade of treatment, n (%)
n = 2091978–1987 (n = 38)1988–1997 (n = 64)1998–2007 (n = 62)2008-2017 (n = 45)P value
Sex
Women14 (36.8)26 (40.6)31 (50.0)25 (55.6)0.049a
Men24 (63.2)38 (59.4)31 (50.0)20 (44.4)
Incidence (No./100000)
Women3.3 (1.8 to 5.5)6.0 (3.9 to 8.8)7.0 (4.8 to 9.9)5.3 (3.4 to 7.8)0.14b
Men5.5 (3.6 to 8.3)8.7 (6.2 to 12.0)7.0 (4.8 to 10.0)4.2 (2.6 to 6.5)0.32b
Age, mean ± SD, years62 ± 1764 ± 1667 ± 1669 ± 170.018c
Hours from symptom debut until admission, mean ± SD)7 ± 98 ± 1216 ± 2913 ± 140.019c
ASA class
II30 (78.9)46 (71.9)33 (53.2)24 (53.3)0.001d
III6 (15.8)13 (20.3)19 (30.6)11 (24.2)
IV2 (5.3)5 (7.8)10 (16.1)9 (20.0)
V0001 (2.2)
Ulcer localisation
Gastric25 (65.8)27 (42.2)26 (41.9)19 (42.2)0.059a
Duodenal13 (34.2)37 (57.8)36 (58.1)26 (57.8)
Past ulcer history5 (13.2)25 (39.1)16 (26.2)00.022a
Smoker at present19 (57.6)40 (64.5)27 (49.1)26 (59.1)0.89a
NSAID use4 (10.5)11 (17.2)19 (31.1)8 (17.8)0.18a
Steroid use2 (5.3)2 (3.1)7 (11.5)3 (6.7)0.42a
Salicylate use2 (5.3)4 (6.3)10 (16.4)8 (17.8)0.025a
Charlson Comorbidity index
026 (68.4)37 (57.8)29 (46.8)18 (40.0)0.003d
15 (13.2)22 (34.4)24 (38.7)13 (28.9)
2+7 (18.4)5 (7.8)9 (14.5)14 (31.1)